Physician

Amy E. Eversole, M.D.

According to 2025 Medicare claims, Amy Eversole, M.D. (NPI: 1760442560) practices cardiology in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from Martin, FL. This provider's primary affiliated billing organization is STUART CARDIOLOGY GROUP LLC (NPI: 1871603332; TIN: 650701827) and primary practice location at 34996-3329. Eversole is affiliated with the Cleveland Clinic Florida Integrated Health (ACO ID: A3588), participating under the MSSP model.

Eversole's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 5,044 traditional Medicare patients, billed 21,544 HCPCS/CPT codes, and received $2,109,036 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 9,840 prescription claims across 1,551 beneficiaries totaling $1,921,766 in drug costs, led by Eliquis (Apixaban). DME data shows 383 claims. Open Payments data shows 78 records totaling $1,500. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $857,661 to $2,109,036. Similarly, Part D prescription costs have moved sharply higher in recent years, from $475,840 to $1,921,766. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $21,130 to $42,543.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,756	10,111	$857,661
2016	2,247	8,190	$673,147
2017	2,238	9,190	$684,095
2018	2,119	8,688	$632,155
2019	2,384	7,693	$616,959
2020	2,724	9,695	$812,106
2021	3,316	13,267	$1,171,507
2022	3,675	14,169	$1,163,601
2023	4,502	17,690	$1,288,052
2024	5,044	21,544	$2,109,036

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	641	5,169	$475,840
2016	612	5,105	$490,421
2017	577	4,685	$470,156
2018	581	4,627	$555,363
2019	661	4,776	$613,340
2020	792	5,547	$762,597
2021	814	5,741	$989,272
2022	1,006	6,642	$1,229,240
2023	1,339	8,346	$1,705,452
2024	1,551	9,840	$1,921,766

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	39	151	$9,157
2016	89	298	$14,092
2017	104	287	$9,857
2018	133	311	$9,202
2019	43	242	$6,927
2020	58	216	$7,356
2021	47	177	$5,964
2022	29	181	$6,981
2023	64	234	$9,854
2024	154	383	$12,834

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	1,081	1,090	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	2,266	3,019	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	837	929	$64
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	920	925	$54
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	2,064	2,463	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	690	44,421	$846,931
Xarelto	Rivaroxaban	298	22,725	$408,882
Entresto	Sacubitril/Valsartan	125	7,315	$150,184
Repatha Sureclick	Evolocumab	152	7,238	$140,434
Nexlizet	Bempedoic Acid/Ezetimibe	55	4,350	$53,707

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	18	121	$3,365
A7032	Cushion for use on nasal mask interface, replacement only, each	N	11	24	$2,104
A7030	Full face mask used with positive airway pressure device, each	N	13	22	$1,803
A7031	Face mask interface, replacement for full face mask, each	N	13	25	$1,716
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	14	28	$1,448

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	78	$1,500	Janssen Pharmaceuticals, Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amy E. Eversole, M.D.?

Tedicare shows public-source Medicare data for Amy E. Eversole, M.D. (NPI 1760442560), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy E. Eversole, M.D. have ACO affiliation data?

Amy E. Eversole, M.D. is shown with ACO affiliation data for Cleveland Clinic Florida Integrated Health (MSSP, ACO ID A3588).

What billing organization is linked to Amy E. Eversole, M.D.?

Amy E. Eversole, M.D. is linked to STUART CARDIOLOGY GROUP LLC (billing NPI 1871603332) in the available physician profile data.

Does Amy E. Eversole, M.D. have Open Payments data?

Amy E. Eversole, M.D. has 78 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.